Abstract

IntroductionIn the SOLO2 trial, olaparib demonstrated a significant benefit in disease-free survival in platinum sensitive recurrent ovarian cancer patients with BRCA1/2 mutations, so importance and utility of poly (adenosine diphosphate-ribose)...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U.A Matulonis ... B.J Monk
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 28
U.A Matulonis, et. al.U.A Matulonis ... B.J Monk
01 Mar 2017
Oncologic outcomes of secondary cytoreductive surgery in the era of poly (ADP-ribose) polymerase inhibitors maintenance (549)
Sarah Ehmann ... Rachel Grisham
Gynecologic oncology | VOL. 166
Sarah Ehmann, et. al.Sarah Ehmann ... Rachel Grisham
01 Aug 2022
430 A phase 1b/II clinical study of AK112, a PD-1/VEGF bispecific antibody, in combination with olaparib in BRCA germline wild-type platinum sensitive recurrent ovarian cancer
Lingying Wu ... Yunxia Li
Journal for ImmunoTherapy of Cancer | VOL. 9
Lingying Wu, et. al.Lingying Wu ... Yunxia Li
01 Nov 2021
Abstract PR06: ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC)
Robert L Coleman ...
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 24
Robert L Coleman, et. al.Robert L Coleman ...
01 Aug 2018
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Predicting outcomes in malignant ovarian germ cell tumors using the modified International Germ Cell Cancer Collaborative Group classification system
Xinyue Zhang ... Jiaxin Yang
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Xinyue Zhang, et. al.Xinyue Zhang ... Jiaxin Yang
16 Jul 2024
Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early high–intermediate or high-risk endometrial cancer
Ruben C G Koek ... Cornelis G Gerestein
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Ruben C G Koek, et. al.Ruben C G Koek ... Cornelis G Gerestein
16 Jul 2024
Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA
Giorgia Dinoi ... Francesco Fanfani
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Giorgia Dinoi, et. al.Giorgia Dinoi ... Francesco Fanfani
13 Jul 2024
Role of V-Y flap reconstruction in vulvar cancer patients: multicenter retrospective study
Violante Di Donato ... Giorgio Bogani
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Violante Di Donato, et. al.Violante Di Donato ... Giorgio Bogani
13 Jul 2024
View more papers